How Can Myeloma Care Providers Engage Patient Interest in Clinical Trials?
How Can Myeloma Care Providers Engage Patient Interest in Clinical Trials? from Patient Empowerment Network on Vimeo.
What are some ways that myeloma care providers can increase interest in clinical trials? Dr. Craig Cole from Karmanos Cancer Institute and advanced practice provider Charise Gleason share insight on information they provide to patients and ways they improve communication about clinical trials.
Download Resource Guide | Descargar guía de recursos
Related Resources:
|
|
|
Transcript:
Dr. Nicole Rochester:
I’m going to go to each of you just to share maybe one takeaway that you’d like to leave with the audience. So I’ll start with you, Dr. Cole, one takeaway.
Dr. Craig Cole:
One takeaway. I actually thought about this, but I think that the biggest takeaway is, if I can squeeze two in.
Is that, is to remember that basically they’re all patients want to be involved in clinical trials and the ownership of having patients on clinical trials is really on us to really talk to them over a longitudinal period, to talk about clinical trials, to have them involved. To not look at a patient saying, “No, they don’t want to be on clinical trial.” That you really engage that patient to tell them about really the incredible progress that we’ve made, how competitive clinical trials are and how exciting it is to be part of that research environment. And that would be my one, my two sort of closing thoughts.
Dr. Nicole Rochester:
And what about you, Ms. Gleason?
Charise Gleason:
Dr. Cole said it well. Please discuss this with your patient. Listen to them. Listen to their concerns. Don’t make decisions for them based on bias that maybe you’re bringing in. Don’t make decisions based on maybe it’s too far. Patients drive hours to go on clinical trials, and let’s give them the information and have that conversation.
